Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Oropharyngeal Neoplasms 7Mouth Neoplasms 7Laryngeal Neoplasms 7Carcinoma 6Hypopharyngeal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Paranasal Sinus Neoplasms 2Lymphoid Interstitial Pneumonia 2Cholangiocarcinoma 2Anus Neoplasms 2Adenocarcinoma of Lung 2Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Stomach Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Sertoli-Leydig Cell Tumor 1

Interventions

pembrolizumab 1fludarabine phosphate 1fludarabine 1berzosertib 1aldesleukin 1Platinum 1Immunoglobulin G 1Gemcitabine 1Cyclophosphamide 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metastatic Bladder Urothelial Carcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02567409 2025-03-03

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
87 enrolled 13 charts
Genitourinary

Metastatic Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡